We believe investors with a long-term horizon should stay invested in MRK stock, while short-term investors should consider ...

Targeted inhibition of a "signal jammer" protein may improve how tumors respond to immunotherapy. Published today in Nature, ...

An expert discusses how medical professionals are increasingly utilizing circulating tumor DNA (ctDNA) and tissue PD-L1 to ...

Researchers also highlighted the significance of TTNT-D as a real-world measure of treatment efficacy, noting it provides ...